About CSOP ASSET MANAGEMENT LTD CHINA HEALTHCARE DISRUPTION INDEX ETF

3174 invests in stocks. The fund's major sectors are Health Technology, with 93.62% stocks, and Technology Services, with 5.66% of the basket. The assets are mostly located in the Asia region.

3174 top holdings are Innovent Biologics, Inc. and Sino Biopharmaceutical Limited, occupying 9.77% and 9.20% of the portfolio correspondingly.

3174 assets under management is ‪400.90 M‬ HKD. It's risen 17.51% over the last month.

3174 fund flows account for ‪973.17 K‬ HKD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

No, 3174 doesn't pay dividends to its holders.

3174 expense ratio is 1.50% meaning you'd have to pay 1.50% of your investment to help manage the fund.

3174 follows the WISE Samsung Group Value Index- KRW - Benchmark Price Return. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

3174 invests in stocks.

3174 price has risen by 29.73% over the last month, and its yearly performance shows a 75.51% increase. See more dynamics on 3174 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 30.54% over the last month, showed a 36.41% increase in three-month performance and has increased by 82.15% in a year.